Cerebral Tissue Oxygenation in Highlanders/Lowlanders
Status
Completed
Conditions
High Altitude Pulmonary Hypertension
Details and patient eligibility
About
The purpose of the current study is to evaluate the cerebral tissue oxygenation of Kyrgyz highlanders with high altitude pulmonary hypertension (HAPH) by performing a longitudinal cohort study. To this end, the investigators will invite the same highlanders who participated in the study in 2012 to undergo follow-up examinations in 2017, in order to allow comparisons of current results with baseline data from 2012.
Enrollment
79 patients
Sex
All
Ages
16+ years old
Volunteers
No Healthy Volunteers
Inclusion criteria
- high altitude pulmonary hypertension confirmed by clinical presentation and mean pulmonary artery pressure >30 mmHg measured by echocardiography at altitude of residence.
- healthy subjects (high altitude controls)
- Both genders
- Age >16 y
- Kyrgyz ethnicity
- born, raised and currently living at >2500 m
- healthy subjects currently living at <1000 m (low altitude controls)
Exclusion criteria
- Pulmonary hypertension from other causes, in particular from left ventricular failure as judged clinically and by echocardiography
- Excessive erythrocytosis
- Other coexistent disorders that may interfere with the cardio-respiratory system and sleep
- Regular use of medication that affects control of breathing
- Heavy smoking
Trial design
79 participants in 3 patient groups
High altitude pulmonary hypertension
Description:
Highlanders with high altitude pulmonary hypertension living above 2500 m.
High altitude control
Description:
Healthy highlanders living above 2500 m.
Low altitude control
Description:
Healthy lowlanders living below 1000 m.
Trial contacts and locations
1
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems